4893 items matching your search terms.

NCIC CTG BR.26: a phase III randomized, double blind, placebo controlled trial of dacomitinib versus placebo in patients with advanced/metastatic non-small cell lung cancer who received prior chemotherapy and an EGFR TKI

Ellis, PM Liu, G Millward, M Perrone, F Shepherd, FA Sun, S Cho, BC Morabito, A Stockler, MR Wierzbicki, R Cohen, V Blais, N Sangha, RS Favaretto, AG Kang, JH Wilson, CF O'Connell, J Ding, K Goss, GC Bradbury, PA

Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial

Ellis, Peter M. Shepherd, Frances A. Millward, Michael Perrone, Francesco Seymour, Lesley Liu, Geoffrey Sun, Sophie Cho, Byoung Chul Morabito, Alessandro Leighl, Natasha B. Stockler, Martin R. Lee, Christopher W. Wierzbicki, Rafal Cohen, Victor Blais, Normand Sangha, Randeep S. Favaretto, Adolfo G. Kang, Jin Hyoung Tsao, Ming-Sound Wilson, Carolyn F. Goldberg, Zelanna Ding, Keyue Goss, Glenwood D. Bradbury, Penelope Ann
LANCET ONCOLOGY, 2014     DOI:10.1016/S1470-2045(14)70472-3

Protocol for the ProCare trial: a phase II randomised controlled trial of shared care for follow-up of men with prostate cancer

Emery, J. Doorey, J. Jefford, M. King, M. Pirotta, M. Hayne, D. Martin, A. Trevena, L. Lim, T. Constable, R. Hawks, C. Hyatt, A. Hamid, A. Violet, J. Gill, S. Frydenberg, M. Schofield, P.
BMJ OPEN, 2014     DOI:10.1136/bmjopen-2014-004972

The Procare trial: a phase II randomised controlled trial of shared care for follow-up of men with prostate cancer

Emery, J. Schofield, P. Jefford, M. King, M. Pirotta, M. Hayne, D. Martin, A. Trevena, L. Lim, T. Constable, R.

A smaller fetal thymus precedes clinical pre-eclampsia: a prospective stud

Eviston, D. Quinton, A. Martin, A. Benzie, R. Peek, M. Nanan, R.
, 2014     DOI:http://dx.doi.org/10.1016/j.preghy.2014.10.036

Overexpression of stem cell markers including prominin 1/CD133 in cardiac mucosa and Barrett's intestinal metaplasia

Falkenback, D. Borodachev, E. Bobryshev, Y. V. Fisher, O. M. Levert-Mignon, A. J. Lord, S.J. Thomas, M. Lord, R. V.
, 2014     DOI:10.1016/S0016-5085(14)63909-3

Quality of life after complete lymphadenectomy for vulvar cancer: do women prefer sentinel lymph node biopsy?

Farrell, R. Gebski, V Hacker, NF
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014     DOI:10.1097/IGC.0000000000000101

Regorafenib in gastrointestinal stromal tumors: clinical evidence and place in therapy

Ferraro, D Zalcberg, J
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2014     DOI:10.1177/1758834014544892

“Not just following what doctors say”: piloting of a decision aid for women considering participation in the Sentinel Node Biopsy versus Axillary Clearance 2 (SNAC2) trial

Fisher, A. Juraskova, I. Butow, P. Bonner, C. Anderson, C. Scarlet, J. Stockler, M. Wetzig, N. Ung, O. Gill, G. Campbell, I.

Cathepsin E is a novel highly overexpressed biomarker in Barrett's esophagus & esophageal adenocarcinoma

Fisher, O. M. Levert-Mignon, A. J. Lord, S.J. Wettstein, A.R. Thomas, M. Falkenback, D. Bobryshev, Y. V. Lord, R. V.
, 2014     DOI:10.1016/S0016-5085(14)63922-6

Impact of estimated GFR reporting on late referral rates and practice patterns for end-stage kidney disease patients: a multilevel logistic regression analysis using the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA)

Foote, C. Clayton, P. A. Johnson, D. W. Jardine, M. Snelling, P. Cass, A.
AMERICAN JOURNAL OF KIDNEY DISEASES, 2014     DOI:10.1053/j.ajkd.2014.02.023

COnsiderations of Nephrologists when SuggestIng Dialysis in Elderly patients with Renal failure (CONSIDER): a discrete choice experiment

Foote, C. Morton, R. L. Jardine, M. Gallagher, M. Brown, M. Howard, K. Cass, A.
NEPHROLOGY, DIALYSIS, TRANSPLANTATION, 2014     DOI:10.1093/ndt/gfu257

Serial next generation sequencing of CFDNA to monitor phase I targeted drug administration

Frenel, J. Carreira, S. Goodall, J. Roda-Perez, D. Smith, A. Mateo, J. Ong, M. Gasi-Tendefelt, D. Yap, T.A. Attard, G. Nava-Rodrigues, D. Molife, L.R. Kaye, S.B. Banerji, U. deBono, J.S.
, 2014     DOI:10.1093/annonc/mdu438

PARAGON (ANZGOG 0903): phase 2 study of anastrozole in women with estrogen/progesterone positive platinum resistant/refractory recurrent ovarian cancer

Friedlander, M. Sjoquist, K. M. Beale, P. Sommeijer, D. W. Mileshkin, L. Martyn, J. McNally, O. O'Connell, R. Grant, P. Hadley, A. Gillies, K. Goh, J. Bonaventura, A.

Measuring subjective improvement of palliative chemotherapy in women with platinum-resistant or -refractory ovarian cancer: the Symptom Benefit study (ANZGOG-0701/ GCIG/PoCoG)

Friedlander, M Stockler, MR Butow, PN Oza, AM O'Connell, F Martyn, J Gillies, K Sjoquist, K King, M ANZGOG and POCOG,